Determinants and associations of health-related quality of life with mortality in acute and chronic heart failure: findings from the ESC HF III Registry

IF 10.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Marjan Walli-Attaei,Lars H Lund,Ramon Luengo-Fernandez,Alastair Gray,Aleksandra Torbica,Radu Huculeci,Victor Aboyans,Adam D Timmis,Panos Vardas,Aldo P Maggioni,José Leal
{"title":"Determinants and associations of health-related quality of life with mortality in acute and chronic heart failure: findings from the ESC HF III Registry","authors":"Marjan Walli-Attaei,Lars H Lund,Ramon Luengo-Fernandez,Alastair Gray,Aleksandra Torbica,Radu Huculeci,Victor Aboyans,Adam D Timmis,Panos Vardas,Aldo P Maggioni,José Leal","doi":"10.1093/ejhf/xuag236","DOIUrl":null,"url":null,"abstract":"Abstract Aims To assess the demographic, clinical, behavioural, and treatment factors associated with health-related quality of life (HRQoL) in heart failure (HF), examine the association between HRQoL and mortality, and evaluate changes in HRQoL over 1-year. Methods We analysed the ESC EORP Heart Failure III Registry, including patients hospitalized with acute HF or outpatient HF visits. HRQoL was assessed using the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Generalized linear models examined associations between demographic, clinical, behavioural, and treatment characteristics with baseline HRQoL. Cox proportional hazards models assessed the relationship between baseline HRQoL and 1-year mortality. Changes in HRQoL were classified as improvement, deterioration, or mixed change across EQ-5D dimensions, and determinants of change were assessed using fixed-effects models. Results Among 10 130 patients (acute HF: 38.6%; outpatient HF: 61.4%), those with acute HF had worse baseline HRQoL than outpatients. Older age, female sex, eGFR ≤29, NYHA class III/IV, and dyspnoea at rest were strongly associated with lower HRQoL in both acute and outpatient HF. Lower baseline HRQoL was associated with a higher risk of death at 1 year, with a 0.1-unit decrease in HRQoL on a scale of −0.59 to 1.00 (equivalent to 37 days of full health lost annually) associated with a 9% higher risk of death; a finding consistent across ejection fraction categories and sex. At 1-year, 45% of patients reported improved HRQoL, and improvements were more common in those with acute HF, mildly reduced ejection fraction, and women. Use of ACEi/ARBs/ARNIs was associated with a modest improvement in HRQoL at 1 year. Conclusions HRQoL provides important clinical information and may provide additional insight into patients’ health status and disease progression beyond conventional clinical measures.","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":"9 1","pages":""},"PeriodicalIF":10.3000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejhf/xuag236","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Aims To assess the demographic, clinical, behavioural, and treatment factors associated with health-related quality of life (HRQoL) in heart failure (HF), examine the association between HRQoL and mortality, and evaluate changes in HRQoL over 1-year. Methods We analysed the ESC EORP Heart Failure III Registry, including patients hospitalized with acute HF or outpatient HF visits. HRQoL was assessed using the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Generalized linear models examined associations between demographic, clinical, behavioural, and treatment characteristics with baseline HRQoL. Cox proportional hazards models assessed the relationship between baseline HRQoL and 1-year mortality. Changes in HRQoL were classified as improvement, deterioration, or mixed change across EQ-5D dimensions, and determinants of change were assessed using fixed-effects models. Results Among 10 130 patients (acute HF: 38.6%; outpatient HF: 61.4%), those with acute HF had worse baseline HRQoL than outpatients. Older age, female sex, eGFR ≤29, NYHA class III/IV, and dyspnoea at rest were strongly associated with lower HRQoL in both acute and outpatient HF. Lower baseline HRQoL was associated with a higher risk of death at 1 year, with a 0.1-unit decrease in HRQoL on a scale of −0.59 to 1.00 (equivalent to 37 days of full health lost annually) associated with a 9% higher risk of death; a finding consistent across ejection fraction categories and sex. At 1-year, 45% of patients reported improved HRQoL, and improvements were more common in those with acute HF, mildly reduced ejection fraction, and women. Use of ACEi/ARBs/ARNIs was associated with a modest improvement in HRQoL at 1 year. Conclusions HRQoL provides important clinical information and may provide additional insight into patients’ health status and disease progression beyond conventional clinical measures.
急性和慢性心力衰竭中与健康相关的生活质量与死亡率的决定因素和关联:来自ESC HF III登记的结果
目的评估心力衰竭(HF)患者与健康相关生活质量(HRQoL)相关的人口学、临床、行为和治疗因素,研究HRQoL与死亡率之间的关系,并评估HRQoL在1年内的变化。方法:我们分析了ESC EORP III型心力衰竭登记,包括急性HF住院患者或门诊HF就诊患者。HRQoL采用EuroQoL 5-Dimension 5-Level (EQ-5D-5L)问卷进行评估。广义线性模型检验了人口统计学、临床、行为和治疗特征与基线HRQoL之间的关系。Cox比例风险模型评估了基线HRQoL与1年死亡率之间的关系。HRQoL的变化在EQ-5D维度上分为改善、恶化或混合变化,并使用固定效应模型评估变化的决定因素。结果在10130例患者中(急性HF: 38.6%;门诊HF: 61.4%),急性HF患者HRQoL基线差于门诊患者。老年、女性、eGFR≤29、NYHA III/IV级、静息时呼吸困难与急性和门诊HF患者HRQoL降低密切相关。较低的基线HRQoL与1年时较高的死亡风险相关,HRQoL在- 0.59至1.00的范围内下降0.1个单位(相当于每年37天的完全健康损失)与死亡风险增加9%相关;这一发现在射血分数类别和性别之间是一致的。1年后,45%的患者报告HRQoL得到改善,改善在急性心衰、射血分数轻度降低和女性患者中更为常见。使用ACEi/ARBs/ARNIs与1年时HRQoL的适度改善相关。结论HRQoL提供了重要的临床信息,可以在常规临床测量之外进一步了解患者的健康状况和疾病进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍: European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书